GLP-1 Daily: Ozempic & Wegovy News
Fewer Employers Cover GLP-1s for Weight Loss in 2027; Walgreens Adds Coverage Help; Vanda Reports Phase 3 Data on a GLP-1 Anti-Vomiting Pill
Wednesday, October 28, 2026 · 7 min
A WTW survey reported by CNBC finds employer coverage of weight-loss GLP-1s falling for the first time in three years, as Walgreens rolls out prior-authorization and Medicare Bridge help. Vanda says its pill tradipitant cut semaglutide-induced vomiting in a company-reported phase 3 trial.
Listen
Show notes
A WTW survey reported by CNBC finds employer coverage of weight-loss GLP-1s falling for the first time in three years, as Walgreens rolls out prior-authorization and Medicare Bridge help. Vanda says its pill tradipitant cut semaglutide-induced vomiting in a company-reported phase 3 trial.
In this episode
- GLP-1 coverage is being dropped by employers: 2027 weight-loss options — CNBC
“A WTW annual health benefits survey fielded over the summer and being released in full on Wednesday found that 53% of employers with more than 100 employees cover GLP-1s for weight loss, down from 57% in 2025. That's the first decline in three years. What's more, 16% of…”
- Walgreens Adds Pharmacist Outreach, Coverage Help for GLP ... — Pharmacy Times
“Walgreens is expanding its weight management services to help eligible patients navigate coverage for glucagon-like peptide-1 (GLP-1) receptor agonists prescribed for weight loss. The additions include virtual care support for commercial insurance checks, prior authorization…”
- Tradipitant Cuts Semaglutide-Induced Vomiting in Phase 3 Trial — Hcplive
“All participants received a single 1 mg dose of semaglutide without the gradual titration used in clinical practice. Vanda described this as a highly emetogenic test condition.”